Year |
Citation |
Score |
2020 |
Winn AN, Fergestrom NM, Pezzin LE, Laud PW, Neuner JM. The impact of generic aromatase inhibitors on initiation, adherence, and persistence among women with breast cancer: Applying multi-state models to understand the dynamics of adherence. Pharmacoepidemiology and Drug Safety. PMID 32196839 DOI: 10.1002/Pds.4995 |
0.322 |
|
2020 |
Beyer KMM, Zhou YM, Laud PW, McGinley E, Yen TW, Nattinger AB. Mortgage discrimination and breast cancer survival among older women in the United States. Journal of Clinical Oncology. 38: e13615-e13615. DOI: 10.1200/Jco.2020.38.15_Suppl.E13615 |
0.375 |
|
2020 |
Neuner JM, Winn AN, Pezzin LE, Laud PW, Nattinger AB, Fergestrom N. Factors associated with adjuvant endocrine therapy adherence in non-metastatic breast cancer. Journal of Clinical Oncology. 38: 533-533. DOI: 10.1200/Jco.2020.38.15_Suppl.533 |
0.373 |
|
2018 |
Kamaraju S, Shi Y, Smith E, Nattinger AB, Laud P, Neuner J. Are Aromatase Inhibitors Associated with Higher Myocardial Infarction Risk in Breast Cancer Patients? A Medicare Population-Based Study. Clinical Cardiology. PMID 30443921 DOI: 10.1002/Clc.23114 |
0.338 |
|
2018 |
Yen TWF, Nattinger AB, McGinley EL, Fergestrom N, Pezzin LE, Laud PW. Investigating the Association Between Advanced Practice Providers and Chemotherapy-Related Adverse Events in Women With Breast Cancer: A Nested Case-Control Study. Journal of Oncology Practice. JOP1800277. PMID 30303759 DOI: 10.1200/Jop.18.00277 |
0.34 |
|
2017 |
Kamaraju S, Smith E, Shi Y, Laud P, Neuner J. Abstract PD4-07: Are aromatase inhibitors associated with higher myocardial infarction risk in breast cancer patients? A Medicare population study Cancer Research. 77. DOI: 10.1158/1538-7445.Sabcs16-Pd4-07 |
0.374 |
|
2016 |
Nattinger AB, Wozniak EM, McGinley EL, Li J, Laud P, Pezzin LE. Socioeconomic Disparities in Mortality Among Women With Incident Breast Cancer Before and After Implementation of Medicare Part D. Medical Care. PMID 28030476 DOI: 10.1097/Mlr.0000000000000685 |
0.345 |
|
2016 |
Biggers A, Shi Y, Charlson J, Smith EC, Smallwood AJ, Nattinger AB, Laud PW, Neuner JM. Medicare D Subsidies and Racial Disparities in Persistence and Adherence With Hormonal Therapy. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 34: 4398-4404. PMID 27998232 DOI: 10.1200/Jco.2016.67.3350 |
0.339 |
|
2016 |
Pezzin LE, Laud P, Neuner J, Yen T, Nattinger AB. A statewide controlled trial intervention to reduce use of unproven or ineffective breast cancer care. Contemporary Clinical Trials. PMID 27521808 DOI: 10.1016/J.Cct.2016.08.005 |
0.326 |
|
2016 |
Charlson J, Smith EC, Smallwood AJ, Laud PW, Neuner JM. Bone Mineral Density Testing Disparities Among Patients With Breast Cancer Prescribed Aromatase Inhibitors. Journal of the National Comprehensive Cancer Network : Jnccn. 14: 875-80. PMID 27407128 DOI: 10.6004/Jnccn.2016.0092 |
0.321 |
|
2016 |
Beyer KM, Zhou Y, Matthews K, Bemanian A, Laud PW, Nattinger AB. New spatially continuous indices of redlining and racial bias in mortgage lending: links to survival after breast cancer diagnosis and implications for health disparities research. Health & Place. 40: 34-43. PMID 27173381 DOI: 10.1016/J.Healthplace.2016.04.014 |
0.325 |
|
2015 |
Neuner JM, Kamaraju S, Charlson JA, Wozniak EM, Smith EC, Biggers A, Smallwood AJ, Laud PW, Pezzin LE. The introduction of generic aromatase inhibitors and treatment adherence among medicare d enrollees. Journal of the National Cancer Institute. 107. PMID 25971298 DOI: 10.1093/Jnci/Djv130 |
0.332 |
|
2015 |
Pezzin LE, Laud P, McGinley E, Nattinger A. Did Medicare Part D reduce socioeconomic disparities in mortality? An analysis of breast cancer patients. Journal of Clinical Oncology. 33: e17602-e17602. DOI: 10.1200/Jco.2015.33.15_Suppl.E17602 |
0.313 |
|
2015 |
Pezzin LE, Charlson JA, McGinley E, Laud P, Neuner JM, Nattinger A. State variation in Medicare Part D and choice of initial endocrine therapy for breast cancer. Journal of Clinical Oncology. 33: 6532-6532. DOI: 10.1200/Jco.2015.33.15_Suppl.6532 |
0.301 |
|
2015 |
Pezzin LE, Laud P, Yen TWF, Neuner J, Nattinger AB. Reexamining the relationship of breast cancer hospital and surgical volume to mortality an instrumental variable analysis Medical Care. 53: 1033-1039. DOI: 10.1097/Mlr.0000000000000439 |
0.372 |
|
2014 |
Neuner J, Smith E, Charlson JA, Pezzin L, Laud P. Medicare Part D low-income subsidy and disparities in breast cancer treatment. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 32: 2. PMID 28141273 DOI: 10.1200/Jco.2014.32.30_Suppl.2 |
0.319 |
|
2013 |
Charlson JA, Smith E, Laud P, Smallwood A, Neuner J. Baseline bone mineral density testing among breast cancer patients prescribed aromatase inhibitors (AIs). Journal of Clinical Oncology. 31: 6642-6642. DOI: 10.1200/Jco.2013.31.15_Suppl.6642 |
0.36 |
|
2013 |
Neuner J, Kamaraju S, Smith E, Charlson J, Smallwood A, Laud P, Pezzin L. Abstract P1-09-01: The effect of generic anastrozole on adherence to adjuvant endocrine therapy Cancer Research. 73. DOI: 10.1158/0008-5472.Sabcs13-P1-09-01 |
0.354 |
|
2011 |
Kong AL, Yen TW, Pezzin LE, Miao H, Sparapani RA, Laud PW, Nattinger AB. Socioeconomic and racial differences in treatment for breast cancer at a low-volume hospital. Annals of Surgical Oncology. 18: 3220-7. PMID 21861226 DOI: 10.1245/S10434-011-2001-Z |
0.344 |
|
2011 |
Yen TW, Czypinski LK, Sparapani RA, Guo C, Laud PW, Pezzin LE, Nattinger AB. Socioeconomic factors associated with adjuvant hormone therapy use in older breast cancer survivors. Cancer. 117: 398-405. PMID 20824718 DOI: 10.1002/Cncr.25412 |
0.322 |
|
2010 |
Nattinger AB, Pezzin LE, Sparapani RA, Neuner JM, King TK, Laud PW. Heightened attention to medical privacy: challenges for unbiased sample recruitment and a possible solution. American Journal of Epidemiology. 172: 637-44. PMID 20660123 DOI: 10.1093/Aje/Kwq220 |
0.334 |
|
2010 |
Yen TW, Sparapani RA, Guo C, Neuner JM, Laud PW, Nattinger AB. Elderly breast cancer survivors accurately self-report key treatment information. Journal of the American Geriatrics Society. 58: 410-2. PMID 20370882 DOI: 10.1111/J.1532-5415.2009.02714.X |
0.357 |
|
2009 |
Yen TW, Fan X, Sparapani R, Laud PW, Walker AP, Nattinger AB. A contemporary, population-based study of lymphedema risk factors in older women with breast cancer. Annals of Surgical Oncology. 16: 979-88. PMID 19194754 DOI: 10.1245/S10434-009-0347-2 |
0.488 |
|
2007 |
Nattinger AB, Laud PW, Sparapani RA, Zhang X, Neuner JM, Gilligan MA. Exploring the surgeon volume outcome relationship among women with breast cancer. Archives of Internal Medicine. 167: 1958-63. PMID 17923595 DOI: 10.1001/Archinte.167.18.1958 |
0.358 |
|
2007 |
Gilligan MA, Neuner J, Zhang X, Sparapani R, Laud PW, Nattinger AB. Relationship between number of breast cancer operations performed and 5-year survival after treatment for early-stage breast cancer. American Journal of Public Health. 97: 539-44. PMID 17267725 DOI: 10.2105/Ajph.2005.075663 |
0.347 |
|
2007 |
Gilligan MA, Neuner J, Sparapani R, Laud PW, Nattinger AB. Surgeon characteristics and variations in treatment for early-stage breast cancer. Archives of Surgery (Chicago, Ill. : 1960). 142: 17-22. PMID 17224496 DOI: 10.1001/Archsurg.142.1.17 |
0.366 |
|
2004 |
Nattinger AB, Laud PW, Bajorunaite R, Sparapani RA, Freeman JL. An algorithm for the use of Medicare claims data to identify women with incident breast cancer. Health Services Research. 39: 1733-49. PMID 15533184 DOI: 10.1111/J.1475-6773.2004.00315.X |
0.348 |
|
2004 |
Neuner JM, Gilligan MA, Sparapani R, Laud PW, Haggstrom D, Nattinger AB. Decentralization of breast cancer surgery in the United States. Cancer. 101: 1323-9. PMID 15368323 DOI: 10.1002/Cncr.20490 |
0.36 |
|
2002 |
Meyer MC, Laud PW. Predictive variable selection in generalized linear models Journal of the American Statistical Association. 97: 859-871. DOI: 10.1198/016214502388618654 |
0.317 |
|
Show low-probability matches. |